Heather Lin

9.9k total citations
173 papers, 4.9k citations indexed

About

Heather Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Heather Lin has authored 173 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 53 papers in Pulmonary and Respiratory Medicine and 52 papers in Cancer Research. Recurrent topics in Heather Lin's work include Breast Cancer Treatment Studies (27 papers), Lung Cancer Treatments and Mutations (25 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Heather Lin is often cited by papers focused on Breast Cancer Treatment Studies (27 papers), Lung Cancer Treatments and Mutations (25 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Heather Lin collaborates with scholars based in United States, Brazil and Egypt. Heather Lin's co-authors include J. Jack Lee, Ignacio I. Wistuba, Isabelle Bedrosian, Yu Shen, William N. William, Carmen Behrens, Simona F. Shaitelman, Gildy V. Babiera, María E. Suarez‐Almazor and Edward S. Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Heather Lin

167 papers receiving 4.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Heather Lin 2.2k 1.6k 1.3k 1.0k 949 173 4.9k
Nicolas Magné 2.2k 1.0× 2.1k 1.3× 1.1k 0.9× 984 1.0× 1.2k 1.3× 318 6.1k
Vincenzo Tombolini 1.5k 0.7× 1.4k 0.9× 1.1k 0.8× 515 0.5× 953 1.0× 224 4.4k
Laura Meyer 2.0k 0.9× 1.6k 1.0× 653 0.5× 803 0.8× 1.6k 1.7× 12 4.6k
William N. William 2.0k 0.9× 1.5k 0.9× 893 0.7× 559 0.6× 901 0.9× 109 4.0k
Emmanuel Chamorey 1.6k 0.8× 1.2k 0.7× 776 0.6× 882 0.9× 1.1k 1.2× 194 4.2k
James R. Egner 2.2k 1.0× 1.7k 1.1× 771 0.6× 742 0.7× 1.8k 1.9× 21 5.0k
P. Kosmidis 3.9k 1.8× 2.3k 1.5× 1.2k 1.0× 817 0.8× 1.0k 1.1× 224 6.4k
Francisco Vera-Badillo 3.4k 1.6× 1.6k 1.0× 754 0.6× 1.2k 1.2× 902 1.0× 76 5.5k
Ashley E. Winkler 3.9k 1.8× 2.5k 1.6× 1.1k 0.9× 848 0.8× 1.4k 1.5× 12 7.3k
Annalisa Trama 2.3k 1.0× 1.9k 1.2× 605 0.5× 575 0.6× 1.1k 1.2× 121 5.3k

Countries citing papers authored by Heather Lin

Since Specialization
Citations

This map shows the geographic impact of Heather Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Lin more than expected).

Fields of papers citing papers by Heather Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Lin. The network helps show where Heather Lin may publish in the future.

Co-authorship network of co-authors of Heather Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Lin. A scholar is included among the top collaborators of Heather Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Lin. Heather Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qin, Upasana Ray, Iqbal Mahmud, et al.. (2025). Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma. Blood. 145(22). 2614–2629. 2 indexed citations
2.
3.
Son, Ji, Heather Lin, Siqing Fu, et al.. (2023). Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer. SHILAP Revista de lepidopterología. 6(1). 10–18. 1 indexed citations
4.
Kuerer, Henry M., Gaiane M. Rauch, Savitri Krishnamurthy, et al.. (2023). 243MO Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial. Annals of Oncology. 34. S280–S280. 1 indexed citations
5.
6.
Thirumurthi, Selvi, Melissa W. Taggart, Bülent Yılmaz, et al.. (2022). Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis. SHILAP Revista de lepidopterología. 5(2). 32–36. 5 indexed citations
7.
Rathore, Richa, Katharine E. Caldwell, Charles R. Schutt, et al.. (2021). Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma. Cell Reports. 34(4). 108678–108678. 38 indexed citations
8.
Boyce-Fappiano, David, Isabelle Bedrosian, Yu Shen, et al.. (2021). Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis. npj Breast Cancer. 7(1). 87–87. 12 indexed citations
9.
Weiss, Anna, Heather Lin, Gildy V. Babiera, et al.. (2019). Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes. Breast Cancer Research and Treatment. 176(2). 435–444. 21 indexed citations
10.
Meraz, Ismail M., Mourad Majidi, Xiaobo Cao, et al.. (2018). TUSC2 Immunogene Therapy Synergizes with Anti–PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras -Mutant Mouse Lung Cancer Models. Cancer Immunology Research. 6(2). 163–177. 42 indexed citations
11.
Shirazi, Fazal, Veerabhadran Baladandayuthapani, Heather Lin, et al.. (2018). Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191. Clinical Cancer Research. 24(24). 6408–6420. 14 indexed citations
12.
Livingston, J. Andrew, Wei‐Lien Wang, Jen-Wei Tsai, et al.. (2018). Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients. Molecular Cancer Therapeutics. 17(6). 1315–1323. 15 indexed citations
13.
Weiss, Anna, Heather Lin, Yu Shen, et al.. (2018). Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Research and Treatment. 169(3). 615–623. 14 indexed citations
14.
Kuiatse, Isere, Veerabhadran Baladandayuthapani, Heather Lin, et al.. (2015). Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia. Clinical Cancer Research. 21(11). 2538–2545. 16 indexed citations
15.
Riquelme, Erick, Carmen Behrens, Heather Lin, et al.. (2015). Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations. Cancer Research. 76(3). 675–685. 85 indexed citations
16.
Riquelme, Erick, Milind Suraokar, Carmen Behrens, et al.. (2014). VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy. Clinical Cancer Research. 20(14). 3849–3861. 59 indexed citations
17.
Behrens, Carmen, Luisa M. Solis, Heather Lin, et al.. (2013). EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma. Clinical Cancer Research. 19(23). 6556–6565. 123 indexed citations
18.
Yang, Fei, Ximing Tang, Erick Riquelme, et al.. (2011). Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy. Cancer Research. 71(16). 5512–5521. 51 indexed citations
19.
Solis, Luisa M., Carmen Behrens, Maria Gabriela Raso, et al.. (2011). Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer. 118(11). 2889–2899. 85 indexed citations
20.
Kies, Merrill S., Floyd Christopher Holsinger, J. Jack Lee, et al.. (2009). Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial. Journal of Clinical Oncology. 28(1). 8–14. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Magné Breakdown of academic impact, for papers by Vincenzo Tombolini Breakdown of academic impact, for papers by Laura Meyer Breakdown of academic impact, for papers by William N. William Breakdown of academic impact, for papers by Emmanuel Chamorey Breakdown of academic impact, for papers by James R. Egner Breakdown of academic impact, for papers by P. Kosmidis Breakdown of academic impact, for papers by Francisco Vera-Badillo Breakdown of academic impact, for papers by Ashley E. Winkler Breakdown of academic impact, for papers by Annalisa Trama
Rankless by CCL
2026